Nanotechnology drug delivery shows promise for treatment of pediatric cancer

Childhood leukemia the focus of research

2012-12-04

(Press-News.org) Wilmington, DE – This month, Molecular Pharmaceutics reported promising findings from the Nemours Center for Childhood Cancer Research and the Materials Science and Engineering Department at the University of Delaware, about the potential for nanotechnology to deliver chemotherapeutic agents in a way that attacks cancer cells without harming healthy cells. To date, nanoparticle-based drug delivery approaches have been poorly developed for the treatment of childhood leukemia, which comprises 30% of childhood cancers. In the Nemours study, encapsulated dexamethasone ("dex") delivered to pre-clinical models with leukemia significantly improved quality of life and survival compared to the control receiving the unencapsulated drug.

Acute lymphoblastic leukemia (ALL) is the most common form of pediatric leukemia. Although 5-year survival rates for ALL approach 90% with available chemotherapy treatments, the deleterious side effects of the drugs, including secondary cancers and fertility, cognitive, hearing, and developmental problems, present a significant concern for survivors and their families. Dex is one of the most commonly used drugs to treat childhood leukemia and long-term systemic exposure to dex causes considerable side effects.

Studies conducted by the lead author A. K. Rajasekaran, PhD, and his team at Nemours in collaboration with Xinqiao Jia, PhD, and her team at the University of Delaware, used polymeric nanoparticles containing chemotherapeutic agents to ensure controlled delivery of drugs to cancer cells in preclinical models. "There are currently seven or eight drugs that are used for chemotherapy to treat leukemia in children," said Dr. Rajasekaran. "They are all toxic and do their job by killing rapidly dividing cells." However, he explained, these drugs don't differentiate cancer cells from other, healthy cells. "The good news is that these drugs are 80-90% effective in curing leukemia. The bad news is that many chemotherapeutic treatments cause severe side effects, especially in children." He posits that it will take researchers hundreds of millions of dollars and many years to find better alternative drug treatments. In the interim, scientists like Dr. Rajasekaran and his colleagues are working on novel ways to deliver existing and affordable drugs to children. "Our polymer synthesis and particle engineering are guided by the clinical need for reducing the side effects of cancer drugs," Dr. Jia commented. Vinu Krishnan, the first author of the study and a chemical engineer and graduate student in Materials Science and Engineering, said, "I am very excited about the results and look forward to taking this to the next level and introducing this approach for the clinical treatment of childhood leukemia". Students in Dr. Jia's group contributing to this work also include Xian Xu and Xiaowei Yang.

To date, advances in nanotechnology have been primarily concentrated around adult cancers. Nanotechnology involves the use of encapsulated particles of drugs that go into the core of the cell. The nanoparticles stick only to the cancer cells and destroy them by delivering the drug precisely, without detecting or harming the normal cells. In preclinical models of leukemia, Dr. Rajasekaran and his team were able to improve survival and quality of life via nanotechnology. Encapsulating the drug uses one third of the typical dose, with good treatment results and no discernible side effects. In addition, the mice that received the drugs delivered via nanoparticles survived longer than those that received the drug administered in the traditional way.

###This work is supported by National Institutes of Health (RO1 DK56216, P20RR016458, P20 RR017716), Delaware Health Sciences Alliance, Andrew McDonough B + Foundation, Caitlin Robb Foundation, Kids Runway for Research, Sones Brothers, Nemours Foundation and funds from the University of Delaware.

About the Nemours Center for Childhood Cancer Research The Nemours Center for Childhood Cancer Research (NCCCR) is an entity of Nemours Biomedical Research and Nemours Center for Cancer and Blood Disorders at the Alfred I. duPont Hospital for Children. The goal of the center is to evolve into a leader in research focusing on biomarkers for childhood cancers and cancers that affect families. The NCCCR works with the Christiana Care Helen F. Graham Cancer Center, the Universityof Delaware Center for Translational Research and the Delaware Biotechnology Institute. The Nemours/Alfred I. duPont Hospital for Children is a division of Nemours, which operates one of the nation's largest health systems devoted to pediatric patient care, teaching, and research. Established as The Nemours Foundation through the legacy and philanthropy of Alfred I. duPont, Nemours offers pediatric clinical care, research, education, advocacy, and prevention programs to families in the communities it serves. Online at www.nemours.org

ELSE PRESS RELEASES FROM THIS DATE:

Study finds prioritizing rather than canvassing entire plant genome may lead to improved crops

2012-12-04

MANHATTAN, Kan. -- A new study may help scientists produce better climate-resistant corn and other food production plants by putting a spin on the notion that we are what we eat. Kansas State University geneticists and colleagues found that by applying a genetic-analysis method used to study and prioritize the genes in humans, it improved the likelihood of finding critical genes in food production plants. These genes control quantitate traits in plants, such as how the plants grow and when they flower. Additionally, this method can be used to study how food production ...

Emergency physician's loss sparks advocacy

2012-12-04

Boston – Jonathan Welch, MD, a physician in the Department of Emergency Medicine at Brigham and Women's Hospital, never thought his family would be part of a medical error. But when his mother's battle with cancer took a sudden turn and she was rushed to a community hospital in Wisconsin, Welch watched in helpless horror as a series of mistakes lead to her death. After the funeral, he encouraged the Wisconsin hospital's administrators to make changes to avoid future errors and deaths, but his experience proved frustrating and fruitless. Now, in an essay that appears ...

Study: Parents key to preventing alcohol, marijuana use by kids

2012-12-04

New research from North Carolina State University, Brigham Young University and the Pennsylvania State University finds that parental involvement is more important than the school environment when it comes to preventing or limiting alcohol and marijuana use by children. "Parents play an important role in shaping the decisions their children make when it comes to alcohol and marijuana," says Dr. Toby Parcel, a professor of sociology at NC State and co-author of a paper on the work. "To be clear, school programs that address alcohol and marijuana use are definitely valuable, ...

Working towards happiness

2012-12-04

Raising the retirement age to increase financial stability does not make men worse off psychologically in the long-run, according to a new study by Dr. Elizabeth Mokyr Horner, from the University of California, Berkeley in the US. Her work shows that individuals go through the same psychological stages as they adjust to retirement, with life satisfaction stabilizing after 70, irrespective of how old they are when they retire. The study is published online in Springer's Journal of Happiness Studies. As we live longer, the size of the retired population relative to that ...

A bridge to the quantum world: Dirac electrons found in unique material

2012-12-04

ANN ARBOR—In a discovery that helps clear a new path toward quantum computers, University of Michigan physicists have found elusive Dirac electrons in a superconducting material. Quantum computers use atoms themselves to perform processing and memory tasks. They promise dramatic increases in computing power because of their ability to carry out scores of calculations at once. They could factor numbers dramatically faster than conventional computers, and would be game-changers for computer security. The combination of properties the researchers identified in a shiny, ...

Predicting the age at menopause of women having suffered from childhood cancers

2012-12-04

This press release is available in French. This study provided important data about the fertility window of women who had suffered from childhood cancer and information concerning the associated risk factors, but did not confirm the greater risk of premature menopause (before the age of 40) that was reported by the American studies. The results were published in the review Human Reproduction of November 15. Women who have suffered from childhood cancer are known to run a greater risk of premature menopause. However, data about the associated risk factors is limited. ...

Multiple media use tied to depression, anxiety

2012-12-04

EAST LANSING, Mich. — Using multiple forms of media at the same time – such as playing a computer game while watching TV – is linked to symptoms of anxiety and depression, scientists have found for the first time. Michigan State University's Mark Becker, lead investigator on the study, said he was surprised to find such a clear association between media multitasking and mental health problems. What's not yet clear is the cause. "We don't know whether the media multitasking is causing symptoms of depression and social anxiety, or if it's that people who are depressed ...

Research shows immune system response is detrimental to novel brain cancer therapy

2012-12-04

Boston -- For the first time, researchers have demonstrated that the response of natural killer (NK) cells is detrimental to glioblastoma virotherapy, a novel way of treating malignant brain cancer by injecting a virus into the tumor. A number of clinical trials are currently underway to test whether glioblastoma virotherapy will facilitate antitumor efficacy, but research led by E. Antonio Chiocca, MD, PhD, chairman of the Department of Neurosurgery at Brigham and Women's Hospital, and published in Nature Medicine, shows that in pre-clinical models, NK cells are killing ...

The radical restructuring of brain networks in comatose patients

2012-12-04

This press release is available in French.The researchers are focusing on analysing brain networks of brain-damaged comatose (non-traumatised) patients, a state where the individual is considered to be unconscious. The authors of the study used an original graph theory-based methodology, where images were constructed using functional MRI data at rest and using robust statistical signal-processing methods. Local and overall effectiveness indices of functional brain networks were obtained for 17 brain-damaged patients and 20 healthy volunteers. Correlations in 417 brain ...

Nature Materials study: Boosting heat transfer with nanoglue

2012-12-04

Troy, N.Y. – A team of interdisciplinary researchers at Rensselaer Polytechnic Institute has developed a new method for significantly increasing the heat transfer rate across two different materials. Results of the team's study, published in the journal Nature Materials, could enable new advances in cooling computer chips and lighting-emitting diode (LED) devices, collecting solar power, harvesting waste heat, and other applications. By sandwiching a layer of ultrathin "nanoglue" between copper and silica, the research team demonstrated a four-fold increase in thermal ...

NFCR congratulates Dr. Robert C. Bast, Jr. on receiving the AACR-Daniel D. Von Hoff Award for Outstanding Contributions to Education and Training in Cancer Research

Nanotechnology drug delivery shows promise for treatment of pediatric cancer

ELSE PRESS RELEASES FROM THIS DATE:

LAST 30 PRESS RELEASES: